<code id='61F8441CCC'></code><style id='61F8441CCC'></style>
    • <acronym id='61F8441CCC'></acronym>
      <center id='61F8441CCC'><center id='61F8441CCC'><tfoot id='61F8441CCC'></tfoot></center><abbr id='61F8441CCC'><dir id='61F8441CCC'><tfoot id='61F8441CCC'></tfoot><noframes id='61F8441CCC'>

    • <optgroup id='61F8441CCC'><strike id='61F8441CCC'><sup id='61F8441CCC'></sup></strike><code id='61F8441CCC'></code></optgroup>
        1. <b id='61F8441CCC'><label id='61F8441CCC'><select id='61F8441CCC'><dt id='61F8441CCC'><span id='61F8441CCC'></span></dt></select></label></b><u id='61F8441CCC'></u>
          <i id='61F8441CCC'><strike id='61F8441CCC'><tt id='61F8441CCC'><pre id='61F8441CCC'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:5
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more
          Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

          AllenG.Breed/APNewbiotechnewsletterlaunchingthisThursday.Don’tmissout.Heythere.Today,wediscusstheimp

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          How to protect coverage of PrEP

          ApharmacistpoursTruvadapills,usedforPrEP,backintothebottleatapharmacyinSanAnselmo,Calif.JustinSulliv